Molecular diagnosis of arthritis due to streptobacillus moniliformis. 2003

Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
Laboratoire de Bactériologie-Hygiène, Hôpital A. Calmette, CHRU de Lille, Lille Cedex, France. fwallet@chru-lille.fr

Streptobacillus moniliformis was identified as etiologic agent of arthritis utilizing a 16S rDNA molecular kit in our clinical laboratory. With the increasing of human contacts with rat as pet, this method would appear suitable to identify fastidious Gram-negative rod involved in arthritis specially when the clinical context is not evocative.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001170 Arthritis, Infectious Arthritis caused by BACTERIA; RICKETTSIA; MYCOPLASMA; VIRUSES; FUNGI; or PARASITES. Arthritis, Bacterial,Arthritis, Septic,Arthritis, Viral,Arthritides, Bacterial,Arthritis, Suppurative,Bacterial Arthritides,Bacterial Arthritis,Infectious Arthritis,Suppurative Arthritis,Septic Arthritis,Viral Arthritis
D012329 RNA, Bacterial Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis. Bacterial RNA
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity

Related Publications

Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
February 1987, Arthritis and rheumatism,
Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
April 1967, JAMA,
Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
January 1951, Marseille medical,
Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
October 1948, The Journal of pediatrics,
Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
September 1948, British medical journal,
Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
October 1950, Journal of the American Medical Association,
Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
June 1947, Journal of bacteriology,
Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
May 1966, British medical journal,
Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
January 1948, Delaware state medical journal,
Frédéric Wallet, and Colette Savage, and Caroline Loïez, and Emilie Renaux, and Patricia Pischedda, and René J Courcol
January 1965, L'Oto-rino-laringologia italiana,
Copied contents to your clipboard!